2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $4.7B | $5.1B | $5.3B | $5.5B | $5.9B |
Cost of Revenue | $2.6B | $2.6B | $2.8B | $2.9B | $3B |
Gross Profit | $2.1B | $2.4B | $2.5B | $2.7B | $2.9B |
Gross Profit % | 45% | 48% | 48% | 48% | 49% |
R&D Expenses | $399M | $415M | $447M | $474M | $518M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $625M | $801M | $649M | $607M | $762M |
Dep. & Amort. | $725M | $667M | $672M | $670M | $680M |
Def. Tax | -$155M | -$88M | -$77M | -$83M | -$115M |
Stock Comp. | $88M | $114M | $125M | $160M | $203M |
Chg. in WC | -$114M | -$61M | -$215M | -$98M | -$185M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $209M | $564M | $440M | $432M | $567M |
ST Investments | $0 | $0 | -$267M | $0 | $3.7M |
Cash & ST Inv. | $209M | $564M | $440M | $432M | $571M |
Receivables | $1.9B | $2.8B | $1.8B | $887M | $3.3B |
Inventory | $193M | $2.1B | $970M | $0 | $0 |
SS&C reported Q1 2025 adjusted revenue of $1.515 billion (up 5.5% YoY), adjusted diluted EPS of $1.44 (up 8.3%), and adjusted consolidated EBITDA of $592 million (up 6.3%) with a margin of 39.1%.
Organic revenue growth was 5.1% in Q1, driven by strong performance in GlobeOp (10.3% organic growth), Wealth and Investment Technologies, and Global Investor and Distribution Solutions; private markets grew 14% and international expansion continued, including new mandates in Australia and a new office in Riyadh.
Cash from operating activities was $272 million (up 51% YoY), with a quarterly cash flow conversion of 74%; SS&C repurchased 2.4 million shares for $207 million and ended the quarter with $515 million in cash and a net leverage ratio of 2.74x.
For Q2 2025, guidance is for revenue of $1.489–$1.529 billion, organic revenue growth of 2.5% at the midpoint, and adjusted diluted EPS of $1.35–$1.41; for full year 2025, revenue guidance is raised to $6.11–$6.24 billion, with 4.4% organic growth at the midpoint and adjusted diluted EPS of $5.68–$6.00.
Management remains optimistic about the pipeline, especially in private markets, AI-driven automation (Blue Prism), and international growth; they are maintaining a conservative outlook for Q2 due to macro uncertainty but expect a ramp in organic growth in the second half of the year from signed deals and new business implementations.